Previous Page  9 / 24 Next Page
Information
Show Menu
Previous Page 9 / 24 Next Page
Page Background

Page 41

Notes:

conferenceseries

.com

Volume 7, Issue 3 (Suppl)

Otolaryngol (Sunnyvale), an open access journal

ISSN:2161-119X

Head, Neck and Plastic Surgery 2017

June 19-20, 2017

June 19-20, 2017 Philadelphia, USA

5

th

Global Summit and Expo on

Head, Neck and Plastic Surgery

Transcranial magnetic stimulation reveals differences between spasmodic dysphonia and muscle

tension dysphonia

Sharyl A Samargia

1

,

2

1

University of Wisconsin-River Falls, USA

2

University of Minnesota-Twin Cities, USA

Statement of the Problem:

Adductor spasmodic dysphonia (AdSD) is a form of focal dystonia resulting in a strained voice

quality during speech tasks. The pathophysiology of AdSD is largely unknown and differential diagnosis is challenging due to

the shared perceptual features with muscle tension dysphonia (MTD). Considering MTD does not have a neurologic-basis,

comparison of cortical excitability, using transcranial magnetic stimulation (TMS), between MTD and AdSD offers a novel

approach in differential diagnosis. A direct comparison of cortical excitability in AdSD and MTD has not previously been

reported.

Methodology:

10 subjects with AdSD, 8 with MTD and 10 healthy controls received single and paired pulse transcranial

magnetic stimulation (TMS) to the primary motor cortex contralateral to tested muscles, first dorsal interosseus (FDI) and

masseter. We hypothesized cortical excitability in AdSD would be significantly different than in MTD and healthy and would

correlate with perceptual severity in AdSD.

Findings:

Cortical silent period (CSP) duration in masseter and FDI were significantly shorter in AdSD than MTD and healthy

controls. Other measures failed to demonstrate differences.

Conclusion & Significance:

There are differences in intracortical excitability between AdSD, MTD and healthy controls.

Differences in intracortical inhibition in FDI and masseter suggest widespread dysfunction of the GABAB (Gamma-Amino-

Butyric Acid Type B) mechanism may be a pathophysiologic feature of AdSD, similar to other forms of focal dystonia. Further

exploration of the use of TMS to assist in the differential diagnosis of AdSD and MTD is warranted.

Biography

Sharyl A Samargia is an Associate Professor and Speech-Language Pathologist. Her expertise is the study of neuroplasticity as it relates to functional motor

recovery in individuals with neurologic disease or injury. She is interested in combining neuromodulation techniques and high intensity, task specific behavioral

practice to facilitate true neural recovery and minimize maladaptive plasticity.

sharyl.samargia@uwrf.edu

Sharyl A Samargia, Otolaryngol (Sunnyvale) 2017, 7:3 (Suppl)

DOI: 10.4172/2161-119X-C1-016